These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8447267)

  • 1. Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia.
    Buxton AE; Kleiman RB; Kindwall KE; Josephson ME
    Am J Cardiol; 1993 Mar; 71(8):695-8. PubMed ID: 8447267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT dispersion in nonsustained ventricular tachycardia and coronary artery disease.
    Bogun F; Chan KK; Harvey M; Goyal R; Castellani M; Niebauer M; Daoud E; Man KC; Strickberger SA; Morady F
    Am J Cardiol; 1996 Feb; 77(4):256-9. PubMed ID: 8607404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionated endocardial electrograms are associated with slow conduction in humans: evidence from pace-mapping.
    Stevenson WG; Weiss JN; Wiener I; Rivitz SM; Nademanee K; Klitzner T; Yeatman L; Josephson M; Wohlgelernter D
    J Am Coll Cardiol; 1989 Feb; 13(2):369-76. PubMed ID: 2913115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in electrophysiological substrate in patients with coronary artery disease and cardiac arrest or ventricular tachycardia. Insights from endocardial mapping and signal-averaged electrocardiography.
    Vaitkus PT; Kindwall KE; Marchlinski FE; Miller JM; Buxton AE; Josephson ME
    Circulation; 1991 Aug; 84(2):672-8. PubMed ID: 1860211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias.
    Cassidy DM; Vassallo JA; Miller JM; Poll DS; Buxton AE; Marchlinski FE; Josephson ME
    Circulation; 1986 Apr; 73(4):645-52. PubMed ID: 3948367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia.
    Hsia HH; Callans DJ; Marchlinski FE
    Circulation; 2003 Aug; 108(6):704-10. PubMed ID: 12885746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia.
    Lin D; Hsia HH; Gerstenfeld EP; Dixit S; Callans DJ; Nayak H; Russo A; Marchlinski FE
    Heart Rhythm; 2005 Sep; 2(9):934-9. PubMed ID: 16171747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia.
    Niebauer M; Daoud E; Goyal R; Chan KK; Harvey M; Bogun F; Castellani M; Man KC; Strickberger SA; Morady F
    Am Heart J; 1996 Mar; 131(3):516-8. PubMed ID: 8604631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.
    Grimm W; Hoffmann J; Menz V; Luck K; Maisch B
    J Am Coll Cardiol; 1998 Sep; 32(3):739-45. PubMed ID: 9741521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic characterization of local abnormal ventricular activities in postinfarction ventricular tachycardia with respect to their anatomic location.
    Komatsu Y; Daly M; Sacher F; Derval N; Pascale P; Roten L; Scherr D; Jadidi A; Ramoul K; Denis A; Jesel L; Zellerhoff S; Lim HS; Shah A; Cochet H; Hocini M; Haïssaguerre M; Jaïs P
    Heart Rhythm; 2013 Nov; 10(11):1630-7. PubMed ID: 23994727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying sites for catheter ablation of ventricular tachycardia.
    Stevenson WG; Sager P; Nademanee K; Hassan H; Middlekauff HR; Saxon LA; Wiener I
    Herz; 1992 Jun; 17(3):158-70. PubMed ID: 1639335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic Chagasic myocarditis.
    de Paola AA; Horowitz LN; Miyamoto MH; Pinheiro R; Ferreira DF; Terzian AB; Cirenza C; Guiguer N; Portugal OP
    Am J Cardiol; 1990 Feb; 65(5):360-3. PubMed ID: 2301265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term reproducibility of ventricular tachycardia induction with electrophysiological testing in patients with coronary heart disease and depressed left ventricular ejection fraction.
    Brembilla-Perrot B; Houriez P; Claudon O; Preiss JP; Beurrier D; Louis P; Terrier de la Chaise A
    Pacing Clin Electrophysiol; 2000 Jan; 23(1):47-53. PubMed ID: 10666753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ventricular fibrillation versus monomorphic ventricular tachycardia during programmed stimulation. Role of premature beat conduction delay.
    Avitall B; McKinnie J; Jazayeri M; Akhtar M; Anderson AJ; Tchou P
    Circulation; 1992 Apr; 85(4):1271-8. PubMed ID: 1372847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation During Sinus Rhythm in Ventricles With Healed Infarction: Differentiation Between Arrhythmogenic and Nonarrhythmogenic Scar.
    Rottmann M; Kleber AG; Barkagan M; Sroubek J; Leshem E; Shapira-Daniels A; Buxton AE; Anter E
    Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e007879. PubMed ID: 31597477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
    Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
    Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic characteristics at initiation of ventricular tachycardia and ventricular fibrillation in a canine infarct model.
    Moroe K; Coelho A; Sampsell RN; Chun YH; Mayrovitz HN; Gosselin AJ
    Clin Cardiol; 1994 Jul; 17(7):384-90. PubMed ID: 7522139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic substrate for sustained ventricular tachycardia in coronary artery disease.
    Josephson ME; Zimetbaum P; Huang D; Sauberman R; Monahan KM; Callans DS
    Jpn Circ J; 1997 Jun; 61(6):459-66. PubMed ID: 9225190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous appearance of endocardial late potentials and ability to induce sustained ventricular tachycardia after procainamide administration.
    Gallagher JD; Fernandez J; Maranhao V; Gessman LJ
    J Electrocardiol; 1986 Apr; 19(2):197-201. PubMed ID: 3486933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.